These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2890913)

  • 21. The adverse effects of fluoroquinolones.
    Smith CR
    J Antimicrob Chemother; 1987 Jun; 19(6):709-11. PubMed ID: 3475267
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of quinolones in staphylococcal infection.
    Shah PM
    J Chemother; 1989 Aug; 1(4):253-6. PubMed ID: 2809692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical role of the quinolones today and in the future.
    Waldvogel FA
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1075-9. PubMed ID: 2620674
    [No Abstract]   [Full Text] [Related]  

  • 24. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
    Edlund C; Nord CE
    Infection; 1988; 16(1):8-12. PubMed ID: 3283041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Delmee M; Avesani V
    Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
    Quentin R; Koubaa N; Cattier B; Gavignet M; Goudeau A
    Antimicrob Agents Chemother; 1988 Jan; 32(1):147-9. PubMed ID: 3258143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.
    Kemmerich B; Small GJ; Pennington JE
    Antimicrob Agents Chemother; 1986 Mar; 29(3):395-9. PubMed ID: 2940970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice.
    Klesel N; Limbert M; Seibert G; Winkler I; Schrinner E
    Infection; 1986; 14 Suppl 1():S36-9. PubMed ID: 2937738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 4-quinolones in the treatment of urinary tract infections.
    Boerema JB
    Pharm Weekbl Sci; 1986 Feb; 8(1):46-52. PubMed ID: 2938070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.
    Groeneveld AJ; Brouwers JR
    Pharm Weekbl Sci; 1986 Feb; 8(1):79-84. PubMed ID: 2938073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinolones: a new class of antimicrobial agents with wide potential uses.
    Neu HC
    Med Clin North Am; 1988 May; 72(3):623-36. PubMed ID: 3280910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gyrase inhibitors: unwanted central nervous system effects].
    Rietbrock N; Staib AH
    Dtsch Med Wochenschr; 1987 Jan; 112(5):201. PubMed ID: 3467948
    [No Abstract]   [Full Text] [Related]  

  • 37. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of 4-quinolones in the treatment of infections.
    Cynamon MH; Wilcox GH
    Compr Ther; 1987 Feb; 13(2):37-43. PubMed ID: 3545658
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical efficacy of the new quinolones in lower respiratory infections.
    Davies BI; Maesen FP
    Chemioterapia; 1987 Jun; 6(2 Suppl):447-8. PubMed ID: 3509469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.